期刊
PHARMACY EDUCATION
卷 21, 期 1, 页码 781-788出版社
INTERNATIONAL PHARMACEUTICAL FEDERATION
DOI: 10.46542/pe.2021.211.781788
关键词
Chronic kidney disease; Medication therapy management; Medication therapy review; Quality of life
Medication therapy management (MTM) involves steps such as medication therapy review, personal medication record, medication-related action plan, intervention or referral, and documentation, which can improve patient knowledge on medicines, decrease non-adherence, and increase efficacy. Studies have shown the positive impact of MTM on geriatric, pediatric, and chronically ill patients, as well as those on polypharmacy.
Medication therapy management (MTM) was first implemented and introduced for chronically ill patients and those taking multiple prescription drugs. The MTM has five steps, namely medication therapy review (MTR), personal medication record (PMR), medication-related action plan (MAP), intervention or referral, and finally, documentation. After receiving MTM services, patients will gain knowledge on medicines, which may decrease non-adherence to treatment and increase its efficacy. Studies have shown the positive impact of MTM on geriatric, pediatric, and chronically ill patients and those on polypharmacy. MTM services may improve medication adherence, decrease healthcare costs, and improve the quality of life (QoL) of patients with chronic kidney disease (CKD) by addressing various issues like anaemia, metabolic acidosis, protein management, fluid management, electrolyte management, dosage adjustment based on eGFR, vaccination, and medication-related problems and intervening with the education about the disease, drugs, and lifestyle modifications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据